Glossary

AJAX progress indicator
Search:
(clear)
  • GDPGood Distribution Practice (GDP) is a standard ensuring that the quality of a medicine is maintained throughout the distribution network, so that authorised medicines are distributed to retail pharmacists and others selling medicines to the general public without any alteration of their properties.
  • Good Laboratory PracticeThe principles of Good Laboratory Practice (GLP) are a quality standard concerned with the organisational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, reported and archived. GLP serves to ensure that(...)
  • GLPThe principles of Good Laboratory Practice (GLP) are a quality standard concerned with the organisational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, reported and archived. GLP serves to ensure that(...)
  • Good Manufacturing PracticeThe purpose of Good Manufacturing Practice (GMP) is to ensure that products are consistently produced according to the appropriate quality standards.The reliability of the quality of products is guaranteed by controlling the five critical parameters: manpower, environment, equipment, methods,(...)
  • GMPThe purpose of Good Manufacturing Practice (GMP) is to ensure that products are consistently produced according to the appropriate quality standards.The reliability of the quality of products is guaranteed by controlling the five critical parameters: manpower, environment, equipment, methods,(...)
  • Good Pharmacovigilance PracticesGood Pharmacovigilance Practice (GVP) is a quality standard for monitoring the safety of medicines and if necessary, taking action to reduce the risks and increase the benefits of medicines. It ensures the detection, collection, assessment, understanding, and prevention of adverse effects with(...)
  • GVPGood Pharmacovigilance Practice (GVP) is a quality standard for monitoring the safety of medicines and if necessary, taking action to reduce the risks and increase the benefits of medicines. It ensures the detection, collection, assessment, understanding, and prevention of adverse effects with(...)
  • Greece's National Organisation for MedicinesGreek National Competent Authority. http://www.eof.gr/
  • EOFGreek National Competent Authority. http://www.eof.gr/
  • Group sequential designGroup sequential design is an example of a statistical approach in clinical trial design. It means that the sample size of the trial is not fixed in advance, and data is sequentially evaluated as it is collected. This is known as interim analysis, and might be carried out at several points in(...)

Find Out More